The World Health Organization (WHO) has advised affected countries by mpox to launch vaccination plans in the areas where the virus is rampant.
The epicenter of the mpox outbreak lies in Congo and neighboring countries such as Burundi, Kenya, Rwanda, and Uganda. The WHO declared an international health emergency for monkeypox on August 14.
Mpox is a viral disease that can be transmitted from animals to humans, but it also spreads through close physical contact. The disease causes fever, muscle aches, and rashes.
Following a monkeypox outbreak in 2022, the WHO had already advised the affected countries to establish a containment and monitoring plan.
In the additional advice, the UN organization addresses countries experiencing a resurgence of the epidemic, including Congo, Burundi, Kenya, Rwanda, and Uganda. They are now advised to develop a vaccination strategy for the areas where cases of the virus have emerged. Additionally, the WHO also recommends cross-border collaboration to monitor suspicious cases of mpox and to provide advice to travelers and transport companies.
Congo’s Minister of Health, Samuel-Roger Kamba, hopes to receive the first vaccines next week. He stated this on Monday evening. The country is the hardest hit with more than 16,700 registered cases and at least 570 deaths since the beginning of the year. The United States has promised 50,000 doses, while Japan pledged 3.5 million doses intended for children on Monday.
Congo, which has approximately 100 million inhabitants, plans to vaccinate four million people, including 3.5 million children. Recently, more and more young people have contracted the disease, according to the minister.
Access to all functionalities is reserved for professional caregivers.
If you are a professional caregiver, you must log in or register for free to gain full access to this content.
Are you a journalist or wish to inform us? Please write to us at [email protected].
Emerging Trends in Mpox Response and Vaccination Strategies
The World Health Organization (WHO) has issued a clear call for countries affected by mpox, also known as monkeypox, to initiate vaccination plans in areas experiencing outbreaks. With the heart of the crisis located in Central Africa, particularly in the Democratic Republic of Congo and its neighboring countries, the urgency for comprehensive public health strategies cannot be overstated.
The WHO designated the situation as an international public health emergency on August 14, highlighting the necessity for robust containment measures. Mpox, which is zoonotic and transmitted through close physical contact, presents symptoms such as fever, muscle pain, and skin rashes—afflictions that can severely impact communities.
Following the mpox outbreak in 2022, WHO recommendations for affected nations included the establishment of monitoring and control plans. The latest advice underscores the importance of a structured vaccination strategy, particularly in countries with rising cases, including Congo, Burundi, Kenya, Rwanda, and Uganda. This multi-pronged approach aims not just to curb the spread but also to ensure that vulnerable populations, notably children and young individuals, are prioritized in vaccination efforts.
In a promising development, the Congolese Health Minister, Samuel-Roger Kamba, has announced the expectation of receiving the first vaccines as early as next week, amidst a staggering toll of over 16,700 registered cases and 570 deaths within the year. International support is on the rise, with the United States pledging 50,000 doses and Japan committing 3.5 million doses targeted at children.
As the Congolese government seeks to vaccinate four million individuals, including approximately 3.5 million children, a significant trend is emerging: the increasing incidence of mpox among younger populations. This shift requires urgent attention not only from local health authorities but also from global health entities to adapt strategies that effectively address modern public health challenges.
Moreover, WHO’s emphasis on cross-border collaboration to monitor suspicious mpox cases and provide travel advisories reflects an understanding of the interconnected nature of health security in our globalized world. This holistic approach may well reshape the response mechanisms to infectious diseases, making vaccination and real-time surveillance essential components of global health policy.